OpenURL Connection Search

Select item for more details and to access through your institution.

Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.
Published in:
1990
By:
- Jacquillat, C.;
- Khayat, D.;
- Banzet, P.;
- Weil, M.;
- Fumoleau, P.;
- Avril, M.-F.;
- Namer, M.;
- Bonneterre, J.;
- Kerbrat, P.;
- Bonerandi, J. J.;
- Bugat, R.;
- Montcuquet, P.;
- Cupissol, D.;
- Lauvin, R.;
- Vilmer, C.;
- Prache, C.;
- Bizzari, J. P.
Publication type:
journal article
Plantar keloids: diagnostic and therapeutic issues in six patients.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2015, v. 29, n. 7, p. 1421, doi. 10.1111/jdv.12625
By:
- Vanhaecke, C.;
- Hickman, G.;
- Cavelier ‐ Balloy, B.;
- Masson, V.;
- Duron, J. ‐ B.;
- Gorj, M.;
- May, P.;
- Schneider, P.;
- Vilmer, C.;
- Bagot, M.;
- Battistella, M.;
- Petit, A.
Publication type:
Article
Toxicoderma by inhalation (fluorocarbides, butane, phenyl-azo-beta-naphthol).
Published in:
1983
By:
- Jeanmougin, M.;
- Bonvalet, D.;
- Civatte, J.;
- Renaud-Vilmer, C.
Publication type:
Case Study
Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Published in:
British Journal of Cancer, 2001, v. 85, n. 12, p. 1883, doi. 10.1054/bjoc.2001.2185
By:
- Moch, C;
- Moysan, A;
- Lubin, R;
- Salmonière, P de La;
- Soufir, N;
- Galisson, F;
- Vilmer, C;
- Venutolo, E;
- Pelletier, F Le;
- Janin, A;
- Basset-Séguin, N
Publication type:
Article
Cutaneous melanoma.
Published in:
British Journal of Cancer, 2001, v. 84, p. 81, doi. 10.1054/bjoc.2001.1771
By:
- Négrier, S;
- Fervers, B;
- Bailly, C;
- Beckendorf, V;
- Cupissol, D;
- Doré, J F;
- Dorval, T;
- Garbay, J R;
- Vilmer, C
Publication type:
Article
Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate.
Published in:
British Journal of Dermatology, 2013, v. 168, n. 4, p. 871, doi. 10.1111/bjd.12038
By:
- Penot, P.;
- Bouaziz, J. ‐ D.;
- Battistella, M.;
- Kerob, D.;
- Pagès, C.;
- Vilmer, C.;
- Basset ‐ Seguin, N.;
- Madjessli, N.;
- Comte, C.;
- Farges, C.;
- Bagot, M.;
- le Maignan, C.;
- Lebbé, C.
Publication type:
Article
Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors.
Published in:
British Journal of Dermatology, 2007, v. 156, n. 3, p. 448, doi. 10.1111/j.1365-2133.2006.07604.x
By:
- Soufir, N.;
- Queille, S.;
- Liboutet, M.;
- Thibaudeau, O.;
- Bachelier, F.;
- Delestaing, G.;
- Balloy, B. C.;
- Breuer, J.;
- Janin, A.;
- Dubertret, L.;
- Vilmer, C.;
- Basset-Seguin, N.
Publication type:
Article

Found: 7

Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.

Plantar keloids: diagnostic and therapeutic issues in six patients.

Toxicoderma by inhalation (fluorocarbides, butane, phenyl-azo-beta-naphthol).

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.

Cutaneous melanoma.

Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate.

Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors.